Page 64 - TI Journal 18-1
P. 64
58 COHEN
Rokka, J.; Karrasch, M.; Parkkola, R.; Rinne, J. 31. Levine, H., 3 . Thioflavin T interaction with
rd
O. Five-year follow-up of 11C-PIB uptake in amyloid b-sheet structures. Amyloi. 2:1-6; 1995.
Alzheimer’s disease and MCI. Eur. J. Nucl. Med. 32. Lopresti, B. J.; Klunk, W. E.; Mathis, C. A.;
Mol. Imaging 41(2):283-289; 2014. Hoge, J. A.; Ziolko, S. K.; Lu, X.; Meltzer, C. C.;
26. Klunk, W. E.; Engler, H.; Nordberg, A.; Wang, Schimmel, K.; Tsopelas, N. D.; DeKosky, S. T.;
Y.; Blomqvist, G.; Holt, D. P.; Bergstrom, M.; Price, J.C. Simplified quantification of Pittsburgh
Savitcheva, I.; Huang, G. F.; Estrada, S.; Ausén, Compound B amyloid imaging PET studies: a
B.; Debnath, M.L.; Barletta, J.; Price, J.C.; Sandell, comparative analysis. J. Nucl. Med. 46(12):1959-
J.; Lopresti, B.J.; Wall, A.; Koivisto, P.; Antoni, 1972; 2005.
G.; Mathis, C.A.; Långström, B. Imaging brain 33. Mathis, C. A.; Wang, Y.; Holt, D. P.; Huang, G.
amyloid in Alzheimer’s disease with Pittsburgh F.; Debnath, M. L.; Klunk, W. E. Synthesis and
Compound-B. Ann. Neurol. 55(3):306-319; 2004. evaluation of 11C-labeled 6-substituted 2-aryl-
27. Klunk, W. E.; Lopresti, B. J.; Ikonomovic, M. D.; benzothiazoles as amyloid imaging agents. J. Med.
Lefterov, I. M.; Koldamova, R. P.; Abrahamson, E. Chem. 46(13):2740-2754; 2003.
E.; Debnath, M. L.; Holt, D. P.; Huang, G. F.; Shao, 34. Mintun, M. A.; Larossa, G. N.; Sheline, Y. I.;
L.; deKosky, S.T.; Price, J.C.; Mathis, C.A. Binding Dence, C. S.; Lee, S. Y.; Mach, R. H.; Klunk, W.
of the positron emission tomography tracer E.; Mathis, C. A.; DeKosky, S. T.; Morris, J. C.
Pittsburgh compound-B reflects the amount [11C]PIB in a nondemented population: poten-
of amyloid-beta in Alzheimer’s disease brain tial antecedent marker of Alzheimer disease.
but not in transgenic mouse brain. J. Neurosci. Neurology 67(3):446-452; 2006.
25(46):10598-10606; 2005. 35. Mormino, E. C.; Kluth, J. T.; Madison, C. M.;
28. Koivunen, J.; Scheinin, N.; Virta, J. R.; Aalto, S.; Rabinovici, G. D.; Baker, S. L.; Miller, B. L.;
Vahlberg, T.; Nagren, K.; Helin, S.; Parkkola, R.; Koeppe, R. A.; Mathis, C. A.; Weiner, M. W.;
Viitanen, M.; Rinne, J. O. Amyloid PET imaging Jagust, W. J. Episodic memory loss is related to
in patients with mild cognitive impairment: a hippocampal-mediated beta-amyloid deposition
2-year follow-up study. Neurology 76(12):1085- in elderly subjects. Brain 132(Pt 5):1310-1323;
1090; 2011. 2009.
29. Landt, J.; D’Abrera, J. C.; Holland, A. J.; Aigbirhio, 36. Mormino, E. C.; Smiljic, A.; Hayenga, A. O.; S, H.
F. I.; Fryer, T. D.; Canales, R.; Hong, Y. T.; Menon, O.; Greicius, M. D.; Rabinovici, G. D.; Janabi, M.;
D. K.; Baron, J. C.; Zaman, S. H. Using positron Baker, S. L.; I, V. Y.; Madison, C. M.; Miller, B.L.;
emission tomography and Carbon 11-labeled Jagust, W.J. Relationships between β-amyloid and
Pittsburgh Compound B to image Brain Fibrillar functional connectivity in different components
beta-amyloid in adults with down syndrome: of the default mode network in aging. Cereb.
safety, acceptability, and feasibility. Arch. Neurol. Cortex 21(10):2399-2407; 2011.
68(7):890-896; 2011. 37. Morris, J. C.; Roe, C. M.; Xiong, C.; Fagan, A.
30. Lao, P. J.; Betthauser, T. J.; Hillmer, A. T.; Price, M.; Goate, A. M.; Holtzman, D. M.; Mintun,
J. C.; Klunk, W. E.; Mihaila, I.; Higgins, A. M. A. APOE predicts amyloid-beta but not tau
T.; Bulova, P. D.; Hartley, S. L.; Hardison, R.; Alzheimer pathology in cognitively normal aging.
Tumuluru, R.V.; Murali, D.; Mathis, C.A.; Cohen, Ann. Neurol. 67(1):122-131; 2010.
A.D.; Barnhart, T.E.; Devenny, D.A.; Mailick, 38. Nebes, R. D.; Snitz, B. E.; Cohen, A. D.; Aizenstein,
M.R.; Johnson, S.C.; Handen, B.L.; Christian, H. J.; Saxton, J. A.; Halligan, E. M.; Mathis, C.
B.T. The effects of normal aging on amyloid-beta A.; Price, J. C.; Kamboh, M. I.; Weissfeld, L. A.;
deposition in nondemented adults with Down Klunk, W.E. Cognitive aging in persons with
syndrome as imaged by carbon 11-labeled minimal amyloid-beta and white matter hyper-
Pittsburgh compound B. Alzheimers Dement. intensities. Neuropsychologia 51(11):2202-2209;
1-11; 2015. 2013.

